Johan Schultz, born in 1960, holds a B.Sc. in chemistry from the University of Uppsala and a Ph.D. in physical chemistry from the University of Stockholm. Schultz carried out many years of academic research in structural biology at EMBL (European Molecular Biology Laboratory (EMBL) in Heidelberg and at the FMP (Forschungsinstitut für Molekulare Pharmakologie) in Berlin before he was recruited to Pharmacia. Schultz has more than 15 years of project management experience in the pharmaceutical industry, both from large pharmacetical companies (Pharmacia Corporation) and biotech companies (Biovitrum, iNovacia and Kancera). Schultz is also the Swedish representative on the board of the European network “Epigenetic Chemical Biology” and is engaged as an expert in the evaluation of applications for EU-funded research .
Back